AKYA: מכפיל EV/EBITDA Akoya Biosciences, Inc.

Due to the neutral status of biomedicine, Akoya Biosciences (AKYA) operates within a stable geopolitical environment. The company's price chart reflects an EV/EBITDA metric of . The business relies on US-based system assembly and reagent production capacities. High barriers to entry are created by unique tissue analysis patents, which compel customers to use only original consumables.

This multiple determines the total enterprise value, including debt, relative to its earnings before interest, taxes, depreciation, and amortization. By analyzing the EV/EBITDA value of the company on the chart, an investor assesses the asset's payback period, excluding the impact of debt load and accounting policies. For Akoya Biosciences (AKYA), this indicator is critical when evaluating capital-intensive developments in spatial biology and tissue imaging.